Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy

www.nature.com

Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy

www.nature.com

botMB to

NatureEnglish · 6 months ago

Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy - Nature

www.nature.com

Type 1 regulatory T cells (Tr1) represent a major obstacle that compromises naturally occurring and therapeutically induced tumour-specific immunity.

You must log in or register to comment.

Chat

Nature

nature

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !nature@rss.ponder.cat

Community locked: only moderators can create posts. You can still comment on posts.

Nature is a weekly international journal publishing the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature also provides rapid, authoritative, insightful and arresting news and interpretation of topical and coming trends affecting science, scientists and the wider public.

Don’t post archive.is links or full text of articles, you will receive a temp ban.

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

10 users / day
53 users / week
254 users / month
886 users / 6 months
2 local subscribers
80 subscribers
2.38K Posts
156 Comments
Modlog